Synergies from RLPL’s acquisition: The acquisition of RLPL would be synergistic for Laurus Labs with benefits likely across the long-term period. Synergies are expected in the area of CDMO business ...

Laurus Labs management said the fundamentals of the company's business remain strong, with sustained growth momentum in the Contract Development and Manufacturing Organization and Generic business.

The stock hit a new high of ₹1,095, appreciated 117% from its 52-week low of ₹504.30 touched on January 28, 2025.

Laurus Labs shares have so far this year surged a whopping 95 per cent, outperforming the Sensex which has advanced 10 per cent. CARE Ratings upgraded Laurus Labs' Long Term Bank Facilities worth Rs 1 ...

Laurus Labs API segment is also well set to clock strong growth backed by the company’s increasing focus to diversify into new therapy areas - anti-diabetes and cardiology along with an eye to gain a ...

Laurus Labs share price opened at an intraday low of ₹358.70 apiece on BSE. (AP Photo/Lo Sai Hung) According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One, Laurus Labs stock ...

Laurus Labs latest update leaves the fair value estimate at roughly ₹821.93 per share with a steady discount rate of 12.76%, underscoring that the market narrative is shifting more on expectations ...

Laurus Labs saw its share price jump 8% in intraday trade on Monday, July 28, hitting a fresh all-time high of ₹901 apiece, even as the Indian stock market remained range bound. The rally followed the ...

Laurus Labs shares tanked 3 per cent in Friday's trade, despite a strong set of March quarter results, led by strong traction in the Formulation segment. This was the second consecutive quarter of ...

Laurus Labs Limited was originally incorporated as Laurus Labs Private Limited on September 19, 2005 at Hyderabad, Andhra Pradesh, India as a private limited company. The company was subsequently ...

Shares of Laurus Labs fell nearly 6 per cent in Tuesday's trade, taking their losing run to the third straight session. Laurus continues to grapple with high industry-wide channel inventory, slower ...

Dr Satyanarayana Chava, CEO, Laurus Labs Image: P Anil Kumar[br]Dr Satyanarayana Chava isn’t afraid of grabbing the bull by its horns. The chief executive of Laurus Labs has probably been asked this ...